NCT00023062
- Conditions
- Basal Ganglia Diseases, Behavior, Brain Diseases, +8 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Clinical trial condition
Parkinson Disease
Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.
1,833 public trials
365 recruiting studies
Parkinson Disease trial results
NCT00001928
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00030979
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00105131
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Completed
The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease
NCT00032812
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00167453
- Conditions
- Basal Ganglia Diseases, Behavior, Brain Diseases, +8 more
- Locations
-
- University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT00311532
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antwerp, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edegem, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ghent, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montigny-le-Tilleul, Belgium
NCT00029809
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Emory University School of Medicine Atlanta, Georgia, United States
Completed
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease
NCT00058838
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
NCT00036218
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Hot Springs, Arkansas, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Carmichael, California, United States
- Pfizer Investigational Site Fresno, California, United States